Table 3 Summary of Patient Characteristics and CyberKnife Dosimetry
From: CyberKnife Stereotactic Radiosurgery for Recurrent, Metastatic, and Residual Hemangiopericytomas
Number of Patients | 14 |
Male | 6 (43%) |
Female | 8 (57%) |
Number of Tumors | 24 |
Number of Tumors with Follow-Up | 22 |
Median Age | 52 years (29 - 70 years) |
Median Follow-Up | 37 months (10 - 73 months) |
Mean Tumor Volume | 9.16 cm3 (0.03 - 56.7 cm3) |
Mean Marginal Dose | 21.2 Gy (16 - 30 Gy) |
Mean Maximum Dose | 26.8 Gy (21.9 - 36.9 Gy) |
Mean Isodose Line | 77.5% (72 - 89%) |
Mean Time to CK Post Surgery | 7.6 years (1 month - 16 years) |
Tumor Reduction | 12 (54.5%) |
Tumor Stable | 6 (27.3%) |
Tumor Recurrence | 4 (18.2%) |
Total Tumor Control | 18 (81.8%) |